Hwang; Tsong-Long

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hwang; Tsong-Long.The latest application filed is for "methods for the treatment of diseases associated with activation of inflammasomes".

Company Profile

5.5.10

Hwang; Tsong-Long - Taoyuan TW
HWANG; Tsong-Long - New Taipei City TW
Hwang; Tsong-Long - Taoyuan City TW
Hwang; Tsong-Long - New Taipei TW
Hwang; Tsong-Long - Tao-Yuan TW
Hwang; Tsong-Long - Kwei-Shan TW

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical composition and use for applying ribociclib in phosphodiesterase 4-mediated disease treatment of patient and inhibition of phosphodiesterase 4 activity Grant 11,351,172 - Hwang , et al. June 7, 2	2022-06-07
Methods For The Treatment Of Diseases Associated With Activation Of Inflammasomes App 20220062270 - HWANG; Tsong-Long ; et al.	2022-03-03
9,11-secosteroids And The Use Of 9,11-secosteroids In Preparing Pharmaceutical Compositions For Inhibiting Inflammation App 20220040199 - Hwang; Tsong-Long ; et al.	2022-02-10
Pharmaceutical Composition And Use For Applying Ribociclib In Phosphodiesterase 4-mediated Disease Treatment Of Patient And Inhibition Of Phosphodiesterase 4 Activity App 20200397789 - HWANG; Tsong-Long ; et al.	2020-12-24
Pharmaceutical Composition And Use For Applying Palbociclib In Disease Treatment Of Patient And Inhibition Of Pi3k Activity App 20200375992 - HWANG; Tsong-Long ; et al.	2020-12-03
Neutrophil inflammation inhibitor and uses thereof Grant 10,654,848 - Hwang , et al.	2020-05-19
Neutrophil Inflammation Inhibitor And Uses Thereof App 20200148674 - HWANG; Tsong-Long ; et al.	2020-05-14
Formyl peptide receptor 1 antagonists and uses thereof Grant 9,895,329 - Hwang , et al. February 20, 2	2018-02-20
FPR1 antagonist derivatives and use thereof Grant 9,593,144 - Hwang , et al. March 14, 2	2017-03-14
Mammalian Sirt1 Activator App 20170035724 - CHEN; Chin-Chuan ; et al.	2017-02-09
Fpr1 Antagonist Derivatives And Use Thereof App 20150307548 - Hwang; Tsong-Long ; et al.	2015-10-29
Oxime-based Compound, Pharmaceutical Composition Containing The Same And Method For Preparing The Same App 20150210636 - Hsieh; Pei-Wen ; et al.	2015-07-30
Oxime-based compound, pharmaceutical composition containing the same and method for preparing the same Grant 9,073,833 - Hsieh , et al. July 7, 2	2015-07-07
Fpr1 Antagonist Derivatives And Use Thereof App 20150099691 - Hwang; Tsong-Long ; et al.	2015-04-09
Benzoxazinone Compound, Method For Producing The Same, And Pharmaceutical Composition Containing The Same App 20110319611 - Hsieh; Pei-Wen ; et al.	2011-12-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.